PBYI
Puma Biotechnology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$9.55
+1.49%Aug 7, 2026, 00:13 UTC
Puma Biotech reported Q2 2026 earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.10 per share, and compared to $0.15 per share a year ago.